Your address will show here +12 34 56 78

JACKSONVILLE, FL / May 18, 2020 / BOTS, Inc. -formerly mCig, Inc. (OTCQB:MCIG) a leading distributor of innovative products, technologies, and services for the global medical cannabis industry – announced today that it has changed its corporate name to BOTS, Inc.  The name change reflects the company’s broader advanced technology commitment and its expertise in driving the innovations needed to shape the future of robotic automation management through digital technology and decentralized blockchain solutions.

“The new name – BOTS, Inc. – allows us to emphasize our wide-ranging business objective around changing the way automation is delivered between service providers and businesses, with the goal of increasing access, lowering costs and improving quality,” said Paul Rosenberg, CEO of the Company. 

During the economic recovery period related to the coronavirus, small and large businesses will be seeking new software automation solutions to enable business continuity and a safer return-to-work. 

Companies want cognitive solutions to make business improvements, enhance existing technologies/processes, helping management make better decisions, and reduce tedious tasks—while repurposing and retraining their human workforce.


Instead of relying on bots that attempt to handle everything automatically, customers will be better served by businesses that find a happy medium between human interaction and robotic process automation.

“Bots and humans—working hand in hand—can form a partnership that benefits employees and their employers,” according to Deloitte consulting research.

The “bots” market size is projected to grow to $9.4 billion by 2024 at a compound annual growth rate (CAGR) of 29.7%.

“Chatbots” (chatbot is a bot application used to conduct an on-line chat conversation via text or text-to-speech) can work in segments such as marketing, payments and processing, and services, but when it comes to revenue, chatbots services currently dominate this sectors market share. According to Lauren Foye, by 2022, banks can automate up to 90% of their customer interaction using chatbots. A survey conducted by Spiceworks showed that 40% of large companies employing more than 500 people plan to implement one or more intelligent assistant or AI-powered chat bots over corporate mobile devices.

According to Adobe, 28% of leading companies use AI for marketing, while 31% plan to use AI in the next 12 months. According to Opus Research, by 2021, 4.5 billion dollars will be invested in chatbots.

While our changed name is already effective in our home state of Puerto Rico, we also applied to FINRA for the symbol change to BOTS and will now apply to have our name similarly reflected in the stock market. We will be implementing this new direction indicated by our name change across the company’s products and services throughout the calendar year 2020 and beyond.

About BOTS, Inc

Headquartered in Jacksonville, Florida, BOTS, Inc (formerly mCig,Inc.) (MCIG) is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands. The Company is committed to drive the innovations needed to shape the future of robotic automation management through digital technology and decentralized blockchain solutions.

The Company has been featured in media nationwide, including CNBC, Bloomberg, TheStreet.com. For more information, visit www.mciggroup.com and our new website under development www.bots.bz 

Visit us on Facebook @ https://www.facebook.com/mCigInc/

Follow us on Twitter @mcigInc

Forward-Looking Statements

This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent the Company’s current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect the opinions of the Company’s management only as of the date of this release. Please keep in mind that the Company is not obligating itself to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as: potential, expect, look forward, believe, dedicated, building, or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by the Company herein are often discussed in filings the Company makes with the United States Securities and Exchange Commission (SEC) available at www.sec.gov and on the Company’s website at www.mciggroup.com.

0

JACKSONVILLE, FL, May 11, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE –mCig, Inc. (MCIG)  CEO Paul Rosenberg publishes an open status letter to Shareholders.

To our Shareholders,

The cannabis industry received a surprise classification during the Covid-19 pandemic, – “essential business.” This may be a harbinger of full legalization to come which should ultimately make our industry far easier to navigate.  It’s not just the US — cannabis legalization and consumption is taking the whole world by storm.

The international advancement towards medical and recreational legalization has dragged marijuana into the mainstream. The whole industry saw a spike in innovation as a result. No longer confined to the edge of the economy, innovative companies in the cannabis space are taking on challenges that the still-developing industry has yet to solve. From product quality assurance to consumption-related, law enforcement, government oversight, taxation issues, banking difficulties- lots of work is still ahead of them.

Visionaries in the cannabis industry are experimenting with using blockchain technology to explore how products can be safer and processes more efficient. Blockchain is revolutionizing the way companies and governments do business – and it will have great benefits for the cannabis industry. People are linking up on cannabis related, blockchain-linked social networks. Expert growers are using blockchain-powered platforms to register new strains and pass along their knowledge to novice growers. Fintech innovators are creating solutions for countless unbanked dispensary customers. Combined, these developments represent the growing impact of blockchain-powered technology in the legal cannabis industry.

The past years have been a demanding learning process that has resulted in discovering that our industry will move to numerous blockchain solutions starting from seed continuing the process to end consumer’s consumption as well as tracking the negative and efficaciousness affects thereof.

In fact, it would not be hard to imagine a world filled with blockchain solutions for every industry from finance to medicine and therefore we will not limit our exposure to the cannabis trade.

In the future, it is likely that most if not all shares, bonds, real estate mortgage transactions will move to blockchain solutions and even NASDAQ and DTCC have substantially delved into this new realm of the future as well as countless other major players.  The impact of the coming transition to blockchain could easily involve trillions of dollars in assets.

The newest components added to this evolution will be AI and robotics as a means to not only make distributed ledgers more efficient but also make them safer, protecting from hackers and malware both in centralized and decentralized environments.

As we seek acquisitions in this quickly expanding field, all of these components, blockchain combined with cryptography, cryptocurrencies, AI and robotics will be highlighted in our quest to position MCIG as a go-to leader.

We are already making moves in this direction, including change of jurisdiction to blockchain and tax friendly Puerto Rico, reserving a new name to match our added direction as well as negotiations under way to acquire a current leader in this field.

Our foresight to add crypto to our portfolio can be seen in a small dividend of Obitx Inc., (OBTX) shares to our shareholders paid years ago while continuing to hold a major stake in this long term investment.

Thank you so much for your ongoing support.  Come grow with us.

Sincerely,

Paul Rosenberg, CEO
MCIG Inc.

About MCIG Group

Headquartered in Jacksonville, Florida, mCig, Inc. (MCIG) is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands.

The Company has been featured in media nationwide, including CNBC, Bloomberg, TheStreet.com. For more information, visit www.mciggroup.com.

Visit us on Facebook @ https://www.facebook.com/mCigInc/

Follow us on Twitter @mcigInc

Forward-Looking Statements

This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent the Company’s current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect the opinions of the Company’s management only as of the date of this release. Please keep in mind that the Company is not obligating itself to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as: potential, expect, look forward, believe, dedicated, building, or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by the Company herein are often discussed in filings the Company makes with the United States Securities and Exchange Commission (SEC) available at www.sec.gov and on the Company’s website at www.mciggroup.com.

0

JACKSONVILLE, FL, March, 13, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – mCig, Inc. (MCIG), an innovative biotech company focused on development and commercialization of over the counter, science-driven, botanical nutrigenetics targeting the endocannabinoid system, medical devices, and research & development today announced execution of a Letter of Intent (LOI) reflecting the Company’s strategic partnership with NJ based, Kaplan Group d/b/a Medical Home Pharmacy (http://www.medicalhomepharmacy.com/,

https://www.youtube.com/watch?v=LWqRacr-ZRY).

Kaplan Group has an extensive history designing personalized, patient-centric programs enhancing health outcomes and experience, and has developed close relationships with hospitals and health systems, community physician practices, among other community referral sources.

Kaplan Group is known for referring hospitals and physicians to innovative research and program development, bringing personalized solutions with a strong track record of driving enhanced patient engagement, health outcomes and satisfaction scores.

Kaplan Group has cultivated patient trust and loyalty that is key to uninhibited patient engagement which will lead to early adoption of (cutting edge) health and wellness solutions. With over four decades of experience, Kaplan Group owns, and operates, state of the art pharmacies equipped with specialty dispensing, and compounding labs, robotic dispensing, and patient friendly packaging solutions.  

Whether servicing high risk, medically complex patients, or those with minimal needs, the approach is always to optimize the unique health and wellness potential for the individual.

Kaplan Group also brings strategic access to international markets, including a network of countries serviced by a centrally located Medical Tourism program.

Ahmet Ugur, an advisor for Kaplan Group states: “Kaplan Group is cultivating relationships with large employers, and labor unions, and will be applying their expertise at a population management level. They’re also exploring new opportunities in research and product development, supply chain management and clinical studies, to offer personalized, precision health and wellness solutions. Accordingly, larger markets will allow for leveraging of scalable, personalized technologies, and disruptive solutions, leading to mutually beneficial opportunities for both parties.”

Accordingly, Kaplan Group sees this aligning very strategically with MCIG’s interest in integrating health & wellness solutions, with access to larger populations.

Paul Rosenberg, MCIG’s Chief Executive Officer, said: “We are excited to partner exclusively with Kaplan Group. MCIG’s strategy is to build a strategic ecosystem of products and services to address the health and wellness multi-billion dollar market that Kaplan Group will sell, promote, and track the outcomes. Kaplan Group brings to the marketplace breakthrough products with cutting edge technologies, and services, this will provide huge opportunities that MCIG looks very much forward to being a part of.”

 

About MCIG Group

Headquartered in Jacksonville, Florida, mCig, Inc. (MCIG) is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands.

The Company has been featured in media nationwide, including CNBC, Bloomberg, TheStreet.com. For more information, visit www.mciggroup.com.

Visit us on Facebook @ https://www.facebook.com/mCigInc/

Follow us on Twitter @mcigInc

 

Forward-Looking Statements

This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent the Company’s current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect the opinions of the Company’s management only as of the date of this release. Please keep in mind that the Company is not obligating itself to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as: potential, expect, look forward, believe, dedicated, building, or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by the Company herein are often discussed in filings the Company makes with the United States Securities and Exchange Commission (SEC) available at www.sec.gov and on the Company’s website at www.mciggroup.com.

Contact:

mCig, Inc.

Paul Rosenberg

[email protected]

0

JACKSONVILLE, FL, Feb. 04, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – mCig, Inc. (MCIG), a vertically integrated company focused on development and commercialization of over the counter, science-driven, botanical nutrigenetics targeting the endocannabinoid system, today announced that its subsidiary (BRRX Clinical) will be launched on Monday, February 10, 2020.

Dale Hipes, CEO of BareRoots-Rx Inc., stated: “We believe the launch of the new site will be an opportunity to set our brand apart from the competition. The site will target individual participants, and it will be responsive to the identification of the members’ health – via the completion of health risk assessments, biometrics, and labs. Once the results are in, an individual will be able to choose various levels of monthly participation allowing them to work towards the goal of (lifestyle) improvements, and well being. The opportunity to craft products specific for the individual is the goal that will assist them in targeting their improvement. Our main objective has always been to assist people in living better, healthy lives.” 

Paul Rosenberg, CEO of mCig, stated: “I am confident that we are moving in the right direction by gearing our products toward individuals with specific goals in mind. Awareness is the first step in advancement and then taking the appropriate action, such as locating the necessary steps to live better. This is the best potential outcome we could hope for with our consumers. We are projecting considerable interest in our forthcoming website and our unique approach to target the healthcare industry.”

About MCIG Group

Headquartered in Jacksonville, Florida, mCig, Inc. (MCIG) is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands.

The Company has been featured in media nationwide, including CNBC, Bloomberg, TheStreet.com. For more information, visit www.mciggroup.com.

Visit us on Facebook @ https://www.facebook.com/mCigInc/

Follow us on Twitter @mcigInc

About BareRoots Rx Inc.

The company focused on the development and commercialization of OTC, science-driven, botanical nutrigenetics, that target the endocannabinoid system. BareRoots Rx Inc. also delivers high-quality consumer and OTC THC-free CBD products that promote overall health and well being as well as state-of-the-art testing and analytics capabilities to our customers.

Forward-Looking Statements

This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent the Company’s current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect the opinions of the Company’s management only as of the date of this release. Please keep in mind that the Company is not obligating itself to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as: potential, expect, look forward, believe, dedicated, building, or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by the Company herein are often discussed in filings the Company makes with the United States Securities and Exchange Commission (SEC) available at www.sec.gov and on the Company’s website at www.mciggroup.com.

0

JACKSONVILLE, FL – (NewMediaWire) – January 27, 2020 – mCig, Inc. (MCIG), a vertically integrated company focused on the development and commercialization of OTC, science-driven, botanical nutrigenetics targeting the endocannabinoid system, today announced the business plan for the nutraceutical joint venture of the Company and Bare Roots, Inc.

BRRX Clinical will operate under two divisions, Consumer Products, and Health Care. The Consumer Products Division will operate much as most other CBD product companies, however, the emphasis will be on products with verifiable efficacy and prescribed dosages. As part of this strategy the company now has three products Registered with an FDA Institutional Review Board (IRB) in Clinical Trials. The first of these, a salve to alleviate the pain from Shingles outbreaks, was announced recently and will be available through a network of independent compounding pharmacies along with two other products also in trials. One of them, a regimen consisting of three packets of a CBD compound ingested daily is targeted at treating liver cirrhosis and fibrosis and is expected to retail for about $400 to $600/month. The last of the three products is a balm targeted at relieving the inflammation from Herpes.

Starting in February, the company will launch its Health Care Division. The core product for this division is a software platform developed over the past 15 years to detect an individual’s predisposition to certain diseases up to three years before symptoms reveal themselves. The platform is a GE/Intel certified program that has been in use for several years. It analyzes blood work, lab results, and genetic information to develop an individual profile that can be used to target that person for certain interventions like a change in diet, supplements or specific exercises.

The launch will start with the BRRX Clinical Subscription Service, a set of services complementing the software platform that will utilize participating clinics and doctor networks to drive consumers to get healthcare before their symptoms require more drastic medical intervention. The plan is for this to be a product marketed to employers, carriers, Physician Networks, and individuals.

According to Dale Hipes, CEO of BRRX Clinical, “We want the focus to be on a holistic approach customized to each client. People can start with a base plan which will have a three-month minimum subscription, and which will develop a blood, genetic, and nutritional profile for each individual. The premium plan is expected to include a week of organic meal service based on an individual’s nutrition plan developed from the initial testing. Members will also have free access to fitness centers, telemedicine services, daily nutraceutical supplements and monthly blood tests in consultation with their physician to identify any bodily changes which could alter their health profile. Additionally, the plan will include catastrophic health insurance and Dental and Vision coverage with required annual checkups.”

The company expects to market the plan through insurance brokers and is conservatively projecting $1 to $2 million in revenue from BRRX Clinical during its first year of operation. This is in addition to the $1.3 million in CBD product orders announced on January 17. New revenue is also expected from the independent pharmacy network as they conduct the aforementioned clinical trials, and from an anticipated CBD cosmetics line to be released later in the year.

Paul Rosenberg, CEO of mCig, Inc., stated: “The clinical subscription service, once launched, could potentially create a significant new revenue stream for mCig. It puts mCig/Bare Roots into a category nothing like any existing CBD company or insurance services provider.”

About MCIG Group

Headquartered in Jacksonville, Florida, mCig, Inc. (MCIG) is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands.

The Company has been featured in media nationwide, including CNBC, Bloomberg, TheStreet.com. For more information, visit www.mciggroup.com.

Visit us on Facebook @ https://www.facebook.com/mCigInc/

Follow us on Twitter @mcigInc

About BareRoots Rx Inc.

The company focused on the development and commercialization of OTC, science-driven, botanical nutrigenetics, that target the endocannabinoid system. BareRoots Rx Inc. also delivers high-quality consumer and OTC THC-free CBD products that promote overall health and well being as well as state-of-the-art testing and analytics capabilities to our customers.

Forward-Looking Statements

This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent the Company’s current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect the opinions of the Company’s management only as of the date of this release. Please keep in mind that the Company is not obligating itself to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as: potential, expect, look forward, believe, dedicated, building, or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by the Company herein are often discussed in filings the Company makes with the United States Securities and Exchange Commission (SEC) available at www.sec.govand on the Company’s website at www.mciggroup.com.

 

Contact:

mCig, Inc.

Paul Rosenberg

[email protected]

0

JACKSONVILLE, FL – (NewMediaWire) – January 23, 2020 – mCig, Inc. (OTCQB:MCIG), vertically integrated company focused on the development and commercialization of OTC, science-driven, botanical nutrigenetics targeting the endocannabinoid system today announced that the nutraceutical joint venture of the Company and BRRx Clinical Inc. is set to move forward with an LOI to supply a national independent compounding pharmacy network. BRRX Clinical will begin releasing the CBD enhanced medical foods/topical applications that are in FDA trials. The products are registered with the International Review Board. The first of these offerings will be for the treatment of shingles. The salve will be valuable not only for protocols established but for addressing the pain that accompanies this diagnosis as well. The Researcher, developer, and advisors have hit the mark in this delivery for relief and a trajectory for reversal of this diagnosis.

Dale Hipes, CEO of BRRX Clinical, states, “We are following a very strategic and well-crafted plan by our senior management team. We are looking forward to many great opportunities to affect change, be the standard for the new Healthcare modalities that Hemp-Derived treatments and capabilities bring to the marketplace.”

Paul Rosenberg, CEO of mCig, Inc., added, “Dale completely changed my view on the whole cannabis industry and the steps the Company should take in order to stay ahead of its competitors. In a few weeks, we are going to introduce our revolutionary BRRx Clinical web portal, which will allow the Company to offer some unique products that will change the lives of millions of people.”

About MCIG Group

Headquartered in Jacksonville, Florida, mCig, Inc. (MCIG) is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands.

The Company has been featured in media nationwide, including CNBC, Bloomberg, TheStreet.com. For more information, visit www.mciggroup.com.

Visit us on Facebook @ https://www.facebook.com/mCigInc/

Follow us on Twitter @mcigInc

About BareRoots Rx Inc.

The company focused on the development and commercialization of OTC, science-driven, botanical nutrigenetics, that target the endocannabinoid system. BareRoots Rx Inc. also delivers high-quality consumer and OTC THC-free CBD products that promote overall health and well being as well as state-of-the-art testing and analytics capabilities to our customers.

Forward-Looking Statements

This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent the Company’s current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect the opinions of the Company’s management only as of the date of this release. Please keep in mind that the Company is not obligating itself to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as: potential, expect, look forward, believe, dedicated, building, or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by the Company herein are often discussed in filings the Company makes with the United States Securities and Exchange Commission (SEC) available at www.sec.gov and on the Company’s website at www.mciggroup.com.

 

Contact: 

mCig, Inc.

Paul Rosenberg

[email protected]

0

JACKSONVILLE, FL – (NewMediaWire) – January 21, 2020 – mCig, Inc. (OTCQB:MCIG), a vertically integrated company focused on the development and commercialization of over the counter, science-driven, botanical nutrigenetics, that target the endocannabinoid system, announces today that the company’s subsidiary, BareRoots Rx, is launching the Co-branding deal with the Tucson Sugar Skulls of the IFL as their exclusive CBD sports partner.

Dale Hipes, CEO of BareRoots, says: “This is a great opportunity for BareRoots to help bring CBD to households in the Arizona region and Nationally throughout the US. The Tucson SugarSkulls (an IFL Franchise) brings a captive audience of more than 3.5 million fans nationally, and over 900,000 fans native to the Tucson area. BareRoots Rx,  and the Tucson SugarSkulls IFL Franchise will be launching for the 2020 season a co-branded CBD line of products to sell along-side other SugarSkulls products and gear.”

Paul Rosenberg, CEO of mCig, Inc., continued: “The rise in popularity for CBD products can be attributed to the consumer’s quest for natural-based health and wellness solutions to treat perpetual ailments, including those derived from athletics such as inflammation, and pain. The hemp-derived CBD market has been estimated to reach US$22 billion by 2022 and the impact of cannabinoids on health, and treatment has not gone unnoticed in professional sports.

“We will leverage the Scottsdale Facility to manufacture and distribute a suite of athlete-focused, CBD performance products, including:

• CBD Therapeutic sleep tinctures;

• CBD Pain tinctures;

• CBD-infused Protein drinks

• CBD-infused balms for optimal topical absorption.” 

MCIG/BareRoots Rx will be having a grand opening of their new facility, located at: 9332 N 95th Way St. B109, Scottsdale, AZ, on January 30, 2020, between 4-7 pm.

Clients, staff, and partners are all welcome to come.

About MCIG Group

Headquartered in Jacksonville, Florida, mCig, Inc. (MCIG) is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands.

The Company has been featured in media nationwide, including CNBC, Bloomberg, TheStreet.com. For more information, visit www.mciggroup.com. Visit us on Facebook @ https://www.facebook.com/mCigInc/Follow us on Twitter @mcigInc

About BareRoots Rx Inc.

The company focused on the development and commercialization of OTC, science-driven, botanical nutrigenetics, that target the endocannabinoid system. BareRoots Rx Inc. also delivers high-quality consumer and OTC THC-free CBD products that promote overall health, and well being, as well as state-of-the-art testing and analytics capabilities to our customers.

Forward-Looking Statements

This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent the Company’s current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect the opinions of the Company’s management only as of the date of this release. Please keep in mind that the Company is not obligating itself to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as: potential, expect, look forward, believe, dedicated, building, or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by the Company herein are often discussed in filings the Company makes with the United States Securities and Exchange Commission (SEC) available at www.sec.govand on the Company’s website at www.mciggroup.com.

Contact:

mCig, Inc.

Paul Rosenberg

[email protected]

0

JACKSONVILLE, FL – (NewMediaWire) – January 17, 2020 – mCig, Inc. (OTCQB:MCIG), vertically integrated company focused on the development and commercialization of over the counter, science-driven, botanical nutrigenetics that target the endocannabinoid system, today announced that the company’s CBD consumer division has agreements to commence this quarter.

MCIG Inc. subsidiary, BareRoots Rx Inc., the consumer products division, has entered into an agreement to distribute 10,000 monthly boxes of the COMPANY’S PROPRIETARY CBD-BASED PRODUCTS to select tribal communities. The company anticipates revenue of approximately $1.1 Mil in its first year of operation under the agreement. It also has entered into a white labeling agreement with cannabis company to supply approximately $200,000 of CBD derivative products.

“This is an important milestone for company in securing new contractual revenue,” noted Paul Rosenberg, President and CEO, MCIG Inc. “This is the first of what we believe will be many derivative product sales and manufacturing agreements for our new facility in Scottsdale, Arizona.”

About MCIG Group

Headquartered in Jacksonville, Florida, mCig, Inc. (MCIG) is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands.

The Company has been featured in media nationwide, including CNBC, Bloomberg, TheStreet.com. For more information, visit www.mciggroup.com. Visit us on Facebook @ https://www.facebook.com/mCigInc/ Follow us on Twitter @mcigInc

About BareRoots Rx Inc.

The company focused on the development and commercialization of OTC, science-driven, botanical nutrigenetics, that target the endocannabinoid system. BareRoots Rx Inc. also deliver high-quality consumer and OTC THC-free CBD products that promote overall health, and well being, as well as state-of-the-art testing and analytics capabilities to our customers.

Forward-Looking Statements

This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent the Company’s current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect the opinions of the Company’s management only as of the date of this release. Please keep in mind that the Company is not obligating itself to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as: potential, expect, look forward, believe, dedicated, building, or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by the Company herein are often discussed in filings the Company makes with the United States Securities and Exchange Commission (SEC) available at www.sec.gov and on the Company’s website at www.mciggroup.com.

Contact: 

mCig, Inc. 

Paul Rosenberg 

[email protected]

0

JACKSONVILLE, FL – (NewMediaWire) – January 13, 2020 – mCig, Inc. (OTCQB: MCIG) today announced that its subsidiary BareRoots has launched a completely redesigned website (www.bareroots-rx.com) and the rebranding of its globally recognized hemp-derived cannabidiol (CBD) products. 

Through the recently created consumer-driven website, the Company hopes that it’s visitors, customers, and consumers will find the website much easier to use. The navigation has been designed to be much simple, products become very easy to access, and add to cart and a well educative CBD section has been added to match consumer’s lifestyle. BareRoots’ products are rebranded and carefully tailored to be consumer-friendly and much comfortable for consumers to maximize their effectiveness by incorporating CBD’s into their daily routines.

BareRoots’ CEO Dale Hipes remarked, “We continue to see a large increase in consumer demand for high-quality CBD products as the U.S. hemp-derived CBD industry is expected to hit $22 billion by 2022.” In a swift response, “We chose to upgrade our website and rebrand our products to create an easy relationship whereby our consumers can educate themselves before making a decision on the products that best fit their needs.” 

In line with the company’s vision, mCig, Inc. CEO Paul Rosenberg responded, “As the level of awareness for CBD continues to grow, it is our top priority to make sure consumers are well informed and educated on all products and fully understand how it’s going to enhance their lifestyle.” Therefore, the rebranded BareRoots’ products not only provide the importance of CBD, but it also provides a comfortable and aesthetically pleasing platform for consumers to use and display in their various homes. 

About MCIG Group

Headquartered in Jacksonville, Florida, mCig, Inc. (MCIG) is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands. 

The Company has been featured in media nationwide, including CNBC, Bloomberg, TheStreet.com. For more information, visit www.mciggroup.com.

Visit us on Facebook @ https://www.facebook.com/mCigInc/

Follow us on Twitter @mcigInc

About BareRoots Rx Inc.

The company focused on the development and commercialization of OTC, science-driven, botanical nutrogenetics, that target the endocannabinoid system. BareRoots Rx Inc. also delivers high-quality consumer and OTC THC-free CBD products that promote overall health and well being as well as state-of-the-art testing and analytics capabilities to our customers. 

Forward-Looking Statements

This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent the Company’s current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect the opinions of the Company’s management only as of the date of this release. Please keep in mind that the Company is not obligating itself to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as: potential, expect, look forward, believe, dedicated, building, or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by the Company herein are often discussed in filings the Company makes with the United States Securities and Exchange Commission (SEC) available at www.sec.govand on the Company’s website at www.mciggroup.com.

 

Contact: 

mCig, Inc.

Paul Rosenberg

[email protected]

0

JACKSONVILLE, FL – (NewMediaWire) – December 12, 2019 – mCig, Inc. (OTCQB:MCIG), a vertically integrated company focused on the development and commercialization of OTC, science-driven, botanical nutrigenetics that target the endocannabinoid system, and Bareroots RX Inc. are expanding their activities collectively in the production and development of lifestyle improvement and health care enhancing CBD (cannabinoid) based products. “As we look forward to 2020, our focus has shifted to a healthcare and medically driven CBD botanical products. We’re committed to adapting to the changing cannabis market in order to maximize our company’s growth. We’re entering a new phase of our development, by building a new company together with Bareroots Rx Inc., which will immediately position us as one of the most innovative players in the field of cannabinoid research and product development. “A new joint company will be one of first to market scientifically backed nutrigenetic CBD based proprietary botanical result driven products, that is so terribly needed in the industry. Our OTC products are made of proprietary recipes based with CBD and are engineered to help with a wide array of targeted conditions that we feel will change Healthcare as we know it,” said Paul Rosenberg, CEO of mCig, Inc. “These robust new proprietary CBD OTC botanical nutrigenetic products will launch in the next 90 days, through our new joint brand ‘BRRX Clinical’. We are excited to be on the same page and trajectory as mCig and Mr. Rosenberg,” said Mr. Dale Hipes, CEO of BareRoots Rx Inc. Mr. Rosenberg concluded by saying, “We are shooting for the top, as it is our intention to deliver the best in class, best in the industry products to date. Continue to watch for coming announcements as we roll out our aggressive 5-year plan. We will change the industry standard from association in the marijuana industry and smoke shops to the real value of botanical solutions for a toxic and stressed environment. We believe, you will not be disappointed when trying the best in class and best brand offered by mCig and Bareroots RX.” About MCIG Group Headquartered in Jacksonville, Florida, mCig, Inc. (MCIG) is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands. The Company has been featured in media nationwide, including CNBC, Bloomberg, TheStreet.com. For more information, visit www.mciggroup.com. Visit us on Facebook @ https://www.facebook.com/mCigInc/ Follow us on Twitter @mcigInc About BareRoots Rx Inc. The company focused on the development and commercialization of OTC, science-driven, botanical nutrigenetics, that target the endocannabinoid system. BareRoots Rx Inc. also deliver high-quality consumer and OTC THC-free CBD products that promote overall health and well being as well as state-of-the-art testing and analytics capabilities to our customers. Forward-Looking Statements This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent the Company’s current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect the opinions of the Company’s management only as of the date of this release. Please keep in mind that the Company is not obligating itself to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as: potential, expect, look forward, believe, dedicated, building, or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by the Company herein are often discussed in filings the Company makes with the United States Securities and Exchange Commission (SEC) available at www.sec.gov and on the Company’s website at www.mciggroup.com. Contact: mCig, Inc. Paul Rosenberg [email protected]
0